Augmedix, Inc. (AUGX) Tops Q3 EPS by 2c

Augmedix, Inc. (NASDAQ: AUGX) reported Q3 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.43 million.

For earnings history and earnings-related data on Augmedix, Inc. (AUGX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Yum! Brands (YUM) PT Lowered to $180 at Argus